Dimensional Fund Advisors Increases Stake in Zimmer Biomet

Investment firm adds 39,146 shares of medical device company

Mar. 8, 2026 at 9:04am

Got story updates? Submit your updates here. ›

Dimensional Fund Advisors LP has increased its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 1.8% in the third quarter, according to a recent SEC filing. The firm now owns 2,269,122 shares of the medical equipment provider's stock, valued at $223,503,000.

Why it matters

Zimmer Biomet is a leading global medical device company focused on musculoskeletal healthcare. Dimensional Fund Advisors' increased stake signals confidence in the company's long-term prospects, as the investment firm is known for its data-driven, systematic approach to investing.

The details

Dimensional Fund Advisors acquired an additional 39,146 shares of Zimmer Biomet during the third quarter, bringing its total holdings to 2,269,122 shares. This represents approximately 1.8% of the company's outstanding shares. Zimmer Biomet is a major manufacturer of joint replacement systems, trauma and extremities implants, and other medical devices used in reconstructive and restorative procedures.

  • Dimensional Fund Advisors increased its stake in Zimmer Biomet during the third quarter of 2026.

The players

Dimensional Fund Advisors LP

A global investment management firm that uses a systematic, data-driven approach to investing.

Zimmer Biomet Holdings, Inc.

A global medical device company focused on musculoskeletal healthcare, headquartered in Warsaw, Indiana.

Got photos? Submit your photos here. ›

The takeaway

Dimensional Fund Advisors' increased stake in Zimmer Biomet suggests the investment firm sees long-term value in the medical device company, which is a leading player in the growing musculoskeletal healthcare market.